Mast cells and inflammation TC Theoharides, KD Alysandratos, A Angelidou, DA Delivanis, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (1), 21-33, 2012 | 937 | 2012 |
Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans Z Weng, B Zhang, S Asadi, N Sismanopoulos, A Butcher, X Fu, ... PloS one 7 (3), e33805, 2012 | 244 | 2012 |
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis B Zhang, KD Alysandratos, A Angelidou, S Asadi, N Sismanopoulos, ... Journal of allergy and clinical immunology 127 (6), 1522-1531. e8, 2011 | 169 | 2011 |
Mast cells regulate wound healing in diabetes A Tellechea, EC Leal, A Kafanas, ME Auster, S Kuchibhotla, Y Ostrovsky, ... Diabetes 65 (7), 2006-2019, 2016 | 158 | 2016 |
The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells Z Weng, AB Patel, S Panagiotidou, TC Theoharides Journal of Allergy and Clinical Immunology 135 (4), 1044-1052. e5, 2015 | 152 | 2015 |
Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions B Zhang, S Asadi, Z Weng, N Sismanopoulos, TC Theoharides PLoS One 7 (12), e49767, 2012 | 142 | 2012 |
SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors TTC Taracanova A, Alevizos M, Karagkouni A, Weng Z, Norwitz E, Conti P ... Proc Natl Acad Sci U S A. 114 (20), E4002-E4009, 2017 | 130* | 2017 |
Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin Z Weng, AB Patel, M Vasiadi, A Therianou, TC Theoharides PloS one 9 (2), e90739, 2014 | 98 | 2014 |
TNF stimulates IL‐6, CXCL 8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin AB Patel, I Tsilioni, Z Weng, TC Theoharides Experimental dermatology 27 (2), 135-143, 2018 | 58 | 2018 |
Luteolin and Thiosalicylate Inhibit HGCL2 and Thimerosal-Induced VEGF Release from Human Mast Cells S Asadi, B Zhang, Z Weng, A Angelidou, D Kempuraj, KD Alysandratos, ... International Journal of Immunopathology and Pharmacology 23 (4), 1015-1020, 2010 | 51 | 2010 |
The “missing link” in autoimmunity and autism: extracellular mitochondrial components secreted from activated live mast cells TC Theoharides, S Asadi, S Panagiotidou, Z Weng Autoimmunity reviews 12 (12), 1136-1142, 2013 | 48 | 2013 |
Stimulated human melanocytes express and release interleukin‐8, which is inhibited by luteolin: Relevance to early vitiligo A Miniati, Z Weng, B Zhang, A Therianou, M Vasiadi, E Nicolaidou, ... Clinical and experimental dermatology 39 (1), 54-57, 2014 | 41 | 2014 |
Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells B Zhang, Z Weng, N Sismanopoulos, S Asadi, A Therianou, ... International archives of allergy and immunology 159 (1), 23-32, 2012 | 39 | 2012 |
Neuro-immuno-endocrine processes in vitiligo pathogenesis A Miniati, Z Weng, B Zhang, AJ Stratigos, E Nicolaidou, TC Theoharides International Journal of Immunopathology and Pharmacology 25 (1), 1-7, 2012 | 33 | 2012 |
Nanotube formation: a rapid form of “alarm signaling”? Z Weng, B Zhang, I Tsilioni, TC Theoharides Clinical Therapeutics 38 (5), 1066-1072, 2016 | 26 | 2016 |
ALKBH5-mediated N6-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation W Song, F Fei, F Qiao, Z Weng, Y Yang, B Cao, J Yue, J Xu, M Zheng, J Li Cell Death Discovery 8 (1), 25, 2022 | 22 | 2022 |
Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs-important considerations of adverse interactions especially for the treatment of myalgic … TC Theoharides, S Asadi, Z Weng, B Zhang Journal of clinical psychopharmacology 31 (4), 403-405, 2011 | 22 | 2011 |
Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2 Y Zhao, Z Weng, X Zhou, Z Xu, B Cao, B Wang, J Li Journal of Translational Medicine 21 (1), 219, 2023 | 7 | 2023 |
Dynamin-related protein 1 expression correlates with psoriasis disease severity and regulates keratinocyte function Z Weng, X Zhou, H Wu, Y Geng, X Zhu, X Xu, J Li European Journal of Dermatology 30, 329-337, 2020 | 3 | 2020 |
The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of single-and multiple-ascending doses Y Yang, L Yu, Z Sheng, H Lin, Z Weng, W Song, B Cao, Y Zhao, Y Gao, ... Frontiers in Pharmacology 15, 1327008, 2024 | | 2024 |